Back to Authors

Fauq, Abdul

Mayo Clinic

Department of Neurosciences, Mayo Clinic, Jacksonville, FL, USA.

Citations 1

Differential Accumulation of Secreted AβPP Metabolites in Ocular Fluids1
Prakasam, A. , Muthuswamy, Anusuya, Ablonczy, Zsolt, Fauq, Abdul H. , Rao, K. S. , Pappolla, Miguel A. , Sambamurti, Kumar , Fauq, Abdul, Greig, Nigel H.

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 20 | Issue: 4 | Pages: 1243-1253

10.3233/jad-2010-100210 Get It

Amyloid-β (Aβ) accumulates in several types of retinal degeneration and in Alzheimer’s disease (AD), but its source has been unclear. We detected the neuronal 695 amino acid form of amyloid-β protein precursor (AβPP) in the normal retina and AβPP751 in the retinal pigment epithelium (RPE) and anterior eye tissues. Similar to the brain, a- and β-secretases cleaved AβPP to soluble derivatives (sAβPP) a or β and membrane-bound C-terminal fragments a or β in the retina and RPE. Levels of sAβPP were particularly high in the vitreous and low in aqueous humor revealing a molecular barrier for AβPP. In contrast, Aβ40 and Aβ42 levels were only 50% lower in the aqueous than the vitreous humor, indicating relatively barrier-free movement of Aβ. These studies demonstrated a relatively high yield of AβPP and Aβ in the ocular fluids, which may serve as a trackable marker for AD. In addition, failure of free clearance from the eye may trigger retina degeneration in a manner similar to Aβ-related neurodegeneration in AD.